Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, is a significant global health concern. This systemic infection, prevalent in regions with poor sanitation and water hygiene, requires adept clinical acumen for diagnosis and management. This article provides a comprehensive guide to the treatment of enteric fever for healthcare professionals.
Diagnosis is primarily based on clinical presentation, with fever, abdominal pain, and constipation being common symptoms. Blood culture remains the gold standard for diagnosis, although it has a sensitivity of only 40-60%. Molecular methods, such as PCR, are increasingly used for their higher sensitivity and specificity.
The cornerstone of enteric fever management is antimicrobial therapy. The choice of antibiotic depends on local susceptibility patterns. Fluoroquinolones were once the drug of choice but increasing resistance has led to the use of third-generation cephalosporins and azithromycin. Empirical therapy should be adjusted based on culture and sensitivity results.
Complications such as intestinal perforation and haemorrhage require immediate surgical intervention. Other complications like myocarditis, hepatitis, and neuropsychiatric manifestations necessitate supportive care alongside antimicrobial therapy.
Prevention strategies include improving sanitation, safe water supplies, and food safety. Vaccination also plays a crucial role in prevention, with two vaccines currently available: the oral live-attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine.
Enteric fever remains a global health challenge, particularly in low-resource settings. Successful management requires a multifaceted approach, encompassing accurate diagnosis, effective antimicrobial therapy, management of complications, and prevention strategies. As healthcare professionals, staying abreast of the latest developments in enteric fever management is crucial to providing optimal patient care.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation